CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
201
Elevance Health
ELV
$69.4B
|
SJ
Sarah James
| $315.09 | $485 |
54%
upside
| Overweight |
23 Apr ‘25
4 months ago |
|
202
Bristol-Myers Squibb
BMY
$95.1B
|
CG
Carter Gould
| $47.23 | $55 |
16%
upside
| Neutral |
23 Apr ‘25
4 months ago |
|
203
Regeneron Pharmaceuticals
REGN
$59.2B
|
CG
Carter Gould
| $556.53 | $695 |
25%
upside
| Overweight |
22 Apr ‘25
4 months ago |
|
204
Pfizer
PFE
$140B
|
CG
Carter Gould
| $24.71 | $24 |
3%
downside
| Neutral |
22 Apr ‘25
4 months ago |
|
205
Merck
MRK
$210B
|
CG
Carter Gould
| $84.61 | $85 |
0%
upside
| Neutral |
22 Apr ‘25
4 months ago |
|
206
Gilead Sciences
GILD
$144B
|
CG
Carter Gould
| $115.76 | $125 |
8%
upside
| Overweight |
22 Apr ‘25
4 months ago |
|
207
AbbVie
ABBV
$371B
|
CG
Carter Gould
| $210.42 | $210 |
0%
downside
| Overweight |
22 Apr ‘25
4 months ago |
|
208
NVIDIA
NVDA
$4.1T
|
MP
Matthew Prisco
| $170.76 | $200 |
17%
upside
| Overweight |
16 Apr ‘25
4 months ago |
|
209
Applied Digital
APLD
$3.64B
|
BK
Brett Knoblauch
| $15.20 | $7 |
54%
downside
| Overweight |
15 Apr ‘25
4 months ago |
|
210
Coinbase
COIN
$77.6B
|
BK
Brett Knoblauch
| $318.78 | $245 |
23%
downside
| Overweight |
8 Apr ‘25
5 months ago |
|
211
Nano X Imaging
NNOX
$257M
|
RO
Ross Osborn
| $3.99 | $9 |
126%
upside
| Overweight |
1 Apr ‘25
5 months ago |
|
|
AARD
212
Aardvark Therapeutics, Inc. Common Stock
AARD
$178M
|
JS
Josh Schimmer
| $7.91 | $50 |
532%
upside
| Overweight |
1 Apr ‘25
5 months ago |
|
213
Tenable Holdings
TENB
$3.77B
|
JR
Jonathan Ruykhaver
| $30.79 | $50 |
62%
upside
| Overweight |
31 Mar ‘25
5 months ago |
|
214
3D Systems Corporation
DDD
$278M
|
TJ
Troy Jensen
| $2.10 | $5 |
138%
upside
| Overweight |
28 Mar ‘25
5 months ago |
|
215
Soleno Therapeutics
SLNO
$3.84B
|
KK
Kristen Kluska
| $70.21 | $123 |
75%
upside
| Overweight |
27 Mar ‘25
5 months ago |
|
216
Sanara MedTech
SMTI
$318M
|
RO
Ross Osborn
| $34.39 | $46 |
34%
upside
| Overweight |
26 Mar ‘25
5 months ago |
|
217
X4 Pharmaceuticals
XFOR
$76.1M
|
KK
Kristen Kluska
| $3.28 | $90 |
2,644%
upside
| Overweight |
26 Mar ‘25
5 months ago |
|
|
ARTV
218
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$75.5M
|
JS
Josh Schimmer
| $2.78 | $20 |
619%
upside
| Overweight |
25 Mar ‘25
5 months ago |
|
219
Ouster
OUST
$1.64B
|
AS
Andres Sheppard
| $28.51 | $11 |
61%
downside
| Overweight |
21 Mar ‘25
5 months ago |
|
220
Titan International
TWI
$565M
|
DS
Derek Soderberg
| $8.35 | $11 |
32%
upside
| Overweight |
20 Mar ‘25
5 months ago |
|
|
MREO
221
Mereo BioPharma
MREO
$285M
|
KK
Kristen Kluska
| $1.82 | $7 |
285%
upside
| Overweight |
18 Mar ‘25
5 months ago |
|
222
Disc Medicine
IRON
$2.15B
|
KK
Kristen Kluska
| $60.34 | $132 |
119%
upside
| Overweight |
18 Mar ‘25
5 months ago |
|
|
BCAX
223
Bicara Therapeutics Inc. Common Stock
BCAX
$671M
|
ES
Eric Schmidt
| $12.46 | $13.01 |
4%
upside
| Overweight |
13 Mar ‘25
6 months ago |
|
224
Redwire
RDW
$1.21B
|
CC
Colin Canfield
| $8.16 | $28 |
243%
upside
| Overweight |
11 Mar ‘25
6 months ago |
|
225
TruBridge
TBRG
$300M
|
SJ
Sarah James
| $19.95 | $29 |
45%
upside
| Overweight |
11 Mar ‘25
6 months ago |
|